-
Tesis Labs raises $20M to expand production, clinical capacity
Phoenix-based genetic sequencing company Tesis Labs raised $20 million of growth equity financing, the company said Oct. 5. The funding round was led by an investment group headed by John Shufeldt, MD. -
Noninvasive tests for colon, prostate cancer unveiled at lab expo
Two research teams have developed noninvasive tests that use blood or saliva samples to diagnose cases of colorectal cancer and prostate cancer. -
Lab test market shifting from provider-driven to consumer-driven
The global direct-to-consumer lab test market is predicted to see 26 percent compound annual growth through 2031, according to a report by Albany, N.Y.-based Transparency Market Research. The growth will likely far outpace that of the overall clinical lab test market's, forecast at a 7.3 percent rate through 2028. -
Testing company to pay up to $70M for San Antonio lab
Welsh point-of-care testing company EKF Diagnostics is acquiring San Antonio-based Advanced Diagnostics Laboratory for $10 million in shares and additional performance-based payments of up to $60 million, the company said Sept. 29. -
Researchers unveil 15-minute test that accurately predicts COVID-19 outcomes
A new rapid test identifies severe COVID-19 patients more accurately than existing tests, researchers said Sept. 29 at the 2021 AACC Annual Scientific Meeting and Clinical Lab Expo in Atlanta. -
Company's shared lab to aid diagnostic test makers with US market hurdles
Rockville, Md.-based lab testing company 20/20 GeneSystems has launched a shared lab to help diagnostic test makers cut the time and cost of launching their tests in the U.S., the company said Sept. 28. -
Preoperative lab testing often wasteful, researchers say
Healthy patients undergoing lab testing before surgery is one of the most common forms of unnecessary, low-value care, according to a study published Sept. 27 in JAMA Internal Medicine. -
Empower Clinics and cybersecurity firm to develop data security program for diagnostic testing
Canadian medical lab firm Empower Clinics, parent company of Dallas-based Kai Medical Lab, is partnering with Canadian cybersecurity company SoLVBL Solutions to provide data security to the diagnostic testing programs Empower uses, the company said Sept. 27. -
Loyola Medicine opens clinical lab in Chicago suburb
Maywood, Ill.-based Loyola Medicine has opened a 30,000-square-foot clinical lab on its main medical center campus, according to commercial real estate outlet REBusiness Online. -
Lab-developed test industry predicted to reach $7B by 2028
The market for lab-developed tests, now worth $4.5 billion globally, is expected to see 7 percent compound annual growth through 2028, according to a new Research and Markets report. -
Spanish firm developing diagnostic tech 1,000 times more sensitive than current lab standard
Spanish startup Mecwins is developing in vitro diagnostic testing lab technology that detects concentrations in femtograms per milliliter — 1,000 times more sensitive than widely available enzyme-linked immunosorbent assays, the company said Sept. 24. -
University of Rochester Medicine to close 11 labs Sept. 28
Staff shortages are forcing the University of Rochester (N.Y.) Medical Center to temporarily close 11 labs, the university said Sept. 23. -
FDA says 2 COVID-19 lab tests might give false positives
Two COVID-19 lab test kits made by Abbott Molecular could show false positive results, the FDA said Sept. 20. -
The biggest issues facing lab directors today
The past two years have caused staffing issues in many areas of healthcare, but medical labs had already been struggling to hire enough people before the COVID-19 pandemic's onset. -
Medical labs will soon see part of $385M CDC funding
The CDC is making a push to bolster medical labs around the country, the agency said Sept. 17. -
Congress could be on verge of giving FDA oversight of lab-developed tests
Congress is considering two bills that would regulate lab tests designed in-house, and the senior author of a new study focused on the tests, published in the Journal of Molecular Diagnostics, said he thinks it's warranted. -
The 10 best cities for lab real estate
Demand in the lab real estate market is driven partially by pharmaceutical sales, which are predicted to grow at a compound annual rate of 7.4 percent through 2026, according to a Sept. 15 report by Chicago-based commercial real estate firm JLL. -
Zai Lab expands into Massachusetts biotech hub
Shanghai-based biopharmaceutical company Zai Lab is ramping up its U.S. operations with a Cambridge, Mass., office, the company said Sept. 16. -
Weill Cornell Medicine to raise $1.5B to expand and upgrade labs
New York City-based Weill Cornell Medicine will build new research labs and upgrade its clinical and virology labs with funds from a $1.5 billion fundraising campaign, the school said Sept. 14. Weill Cornell has raised more than half that so far. -
Tesis Labs partners with Georgia's Premier Health to offer preventive testing
Phoenix-based genetic sequencing company Tesis Labs is partnering with Atlanta-based Premier Health to offer genetic testing to patients in the state, Tesis said Sept. 15.
Page 12 of 50